On March 10, 2025, Cửu Long Pharmaceutical Joint Stock Company successfully organized the EU-GMP forum with the theme “Expert Consultation – Dialogue from Practice.”
The event demonstrated Cửu Long Pharmaceutical’s commitment to striving for the highest standards in the pharmaceutical industry today, aiming to build a sustainable development strategy that helps the company stand firm in an increasingly competitive market.
The EU-GMP forum attracted the interest of experts on EU-GMP standards in particular and those interested in the development of the pharmaceutical industry in general. The event was attended by Mr. Nguyễn Văn Bản – CEO of F.I.T Group; Mrs. Nguyễn Thị Thu Hường – CEO of Cửu Long Pharmaceutical Joint Stock Company, and Assistant to the Chairman of the Board, Internal Operations of Dược Cửu Long; Mr. Nguyễn Trọng Đức – Deputy CEO of Production & SC DCL; Mr. Nguyễn Bá Thế – Business Development Director; Mr. Đỗ Minh Sĩ – Technical Director (QA, QC, R&D). The expert delegation was led by Mr. Đào Xuân Hưởng – Chairman of the Board of GMPC Vietnam, with an Indian expert team led by Mr. Rohit Ochaney – Co-founder and CEO of Inotek India.
“This forum today is also an opportunity for us to connect and share practical experiences, creating a solid foundation for the sustainable development of the pharmaceutical manufacturing industry, while also promoting the process of transformation and improving product quality to meet international standards in the most effective way,” said Mrs. Nguyễn Thị Thu Hường, CEO of Cửu Long Pharmaceutical Joint Stock Company.
Mrs. Nguyễn Thị Thu Hường speaking at the event.
At the first session of the forum, Mr. Rohit Ochaney – Co-founder and CEO of Inotek India presented a talk answering the question: Why is the application of the EU-GMP standard an essential factor in the pharmaceutical industry of the 21st century? “In today’s globalization trend, applying EU-GMP is not only a mandatory requirement for exporting products to demanding markets like the EU but also an important factor for pharmaceutical companies to increase competitiveness and expand their market share in the international market,” Mr. Rohit Ochaney shared.
Mr. Rohit Ochaney – An expert from India sharing the importance of EU-GMP standards in the 21st-century pharmaceutical industry.
Also during the forum, Mr. Đào Xuân Hưởng – Chairman of the Board of GMPC Vietnam shared his passionate insights into practical experience in building an EU-GMP standard factory in Vietnam. With many years of experience, Mr. Đào Xuân Hưởng provided valuable insights into each critical stage in the factory construction process, from selecting locations and designing the facilities to equipping modern production lines that strictly comply with quality standards.
The second session of the forum was marked by a roundtable discussion with experts Mr. Đào Xuân Hưởng, Mr. Rohit Ochaney, and two experts from Cửu Long Pharmaceutical: Mr. Đỗ Minh Sĩ – Technical Director (QA, QC, R&D), and Mr. Mai Khắc Tùng – Assistant to the Chairman of the Board.
QA, QC, R&D professionals, and Investment Management Department staff directly discussed with the four experts regarding issues related to ensuring quality management systems; meeting quality control requirements throughout the entire production chain; seeking new methods and technologies to enhance the accuracy in quality inspection; developing new products that fully comply with EU-GMP quality standards; upgrading factory infrastructure to meet EU-GMP requirements, etc.
Experts answering Cửu Long’s staff questions related to EU-GMP.
After four hours of discussion, the forum provided concrete solutions to address the difficulties in implementing and maintaining the EU-GMP standard. This was also an opportunity for Cửu Long Pharmaceutical and the expert delegation to exchange experiences in applying the EU-GMP standard, further strengthening the cooperative relationship between the parties, and opening new directions to enhance competitiveness and achieve sustainable development.
The forum reflects Cửu Long Pharmaceutical’s determination to achieve the EU-GMP standard.
With the knowledge and solutions shared during the forum, Cửu Long Pharmaceutical is consolidating its ability to meet quality requirements and gradually moving towards realizing its vision of becoming the most highly regarded pharmaceutical company in Vietnam, praised by patients, partners, and employees through innovative, accessible products, and the best care services.
